Dublin, Jan. 06, 2026 (GLOBE NEWSWIRE) — The “Artificial Intelligence (AI) in Predictive Toxicology Global Market Opportunities and Strategies to 2034” has been added to ResearchAndMarkets.com’s offering.
The global artificial intelligence (AI) in predictive toxicology market is on a robust growth trajectory, expanding from $495.44 million in 2024 to a projected $6.05 billion by 2034. The historic period through 2024 witnessed a remarkable compound annual growth rate (CAGR) of 30.62%, bolstered by a shift toward plant-based products, expansion in the pharmaceutical sector, and an increased emphasis on health and wellness. Despite regulatory hurdles and high production costs, the market has poised itself for continued expansion.
Looking ahead, the cosmetics industry and dietary supplements market bring forth notable opportunities alongside the growing demand for natural antioxidants. Though challenges such as limited clinical validation and potential impacts of trade tensions exist, the landscape remains promising. North America leads the market with a 40.13% share, followed closely by Asia-Pacific, which is anticipated to demonstrate the fastest regional growth at a CAGR of 35.01% through 2029.
The competitive landscape is notably fragmented, with the top ten players holding a combined market share of 17.72% in 2024. Leading entities include Simulations Plus Inc. (3.25% market share), Certara Inc., Schrodinger Inc., and Merative LP (formerly IBM Watson Health). Key market segments are primarily led by solutions (69.24% share) and machine learning technology (47.51% share), both of which are expected to experience significant growth through 2029.
The genotoxicity segment, representing 33.19% of the market in 2024, stands out with expected rapid advancement. Pharmaceutical and biotechnology companies are identified as the dominant end users, contributing nearly half of the market share. The sector is poised for growth, emphasizing AI-driven risk assessments and transformative AI platforms to enhance research and drug safety outcomes
Opportunities abound in machine learning, projected to gain $711.52 million in annual sales by 2029, alongside the thriving genotoxicity segment and pharmaceutical-biotechnology domain. The U.S. market is positioned as a key contributor, anticipated to add $382.21 million to its market size.
Market strategic trends highlight the launch of innovative AI-driven platforms, aimed at revolutionizing risk assessments, expanding digital pathology collaborations, and enhancing therapeutic efficacy predictions. Key strategies include leveraging AI modules to replace animal testing and intensifying collaborations across rapidly growing sectors
To capitalize on these prospects, companies are encouraged to enhance AI integration in toxicity assessments, scale machine learning capabilities, and reinforce their positions in both emerging and established markets. By providing competitive offerings and leveraging business-to-business promotions, stakeholders can deepen their engagement with pharmaceutical and biotechnology end users.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 340 |
| Forecast Period | 2024 – 2034 |
| Estimated Market Value (USD) in 2024 | $495.4 Million |
| Forecasted Market Value (USD) by 2034 | $6050 Million |
| Compound Annual Growth Rate | 28.4% |
| Regions Covered | Global |
Chapters Covered:
- Market Characteristics: Insights into market segmentations by component, technology, toxicity endpoints, and end users.
- Key Trends: An exploration of major market trends and future developments.
- Growth and Strategy Analysis: PESTEL and other frameworks to understand market drivers and restraints, historical and forecast growth, and total addressable market (TAM).
- Global Market Overview: Historical and future market values, drivers, and restraints.
- Regional Insights: In-depth regional and country-specific market analysis.
- Competitive Landscape: Analysis of market competition, market shares, and profiles of leading players.
- Market Opportunities and Strategies: Insights into growth opportunities and strategic actions across regions and segments.
Markets Covered:
- By Component: Solution; Services
- By Technology: Machine Learning; Natural Language Processing; Computer Vision; Other Technologies
- By Toxicity Endpoints: Genotoxicity; Hepatotoxicity; Neurotoxicity; Cardiotoxicity; Other Endpoints
- By End User: Pharmaceutical and Biotechnology Companies; Chemical and Cosmetics; Contract Research Organizations; Other End Users
Companies Featured
- Simulations Plus Inc.
- Certara Inc.
- Schrodinger Inc.
- Merative LP (formerly IBM Watson Health)
- BIOVIA (a Dassault Systemes company)
- Cyprotex
- Evalueserve Holding AG
- Recursion Pharmaceuticals Inc.
- Eurofins Scientific SE
- Charles River Laboratories International
- Standigm
- Schrodinger
- Certara
- Recursion Pharmaceuticals
- Chemaxon
- Insilico Medicine
- ArisGlobal
- Valo Health
- NVIDIA Corporation
- PharmCADD
- Syntekabio
- AIGEN Sciences
- Pharmaron
- Syngene International Ltd
- BIOVIA
- SyntheticGestalt
- Simulations Plus
- Exscientia plc
- Lhasa Limited
- BenevolentAI
- Causaly
- Ardigen
- Molecular Devices LLC
- Instem
- Medidata Solutions Inc.
For more information about this report visit https://www.researchandmarkets.com/r/vjbuyq
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Artificial Intelligence (AI) in Predictive Toxicology Market
